Rocket Pharmaceuticals, Inc.

A fully integrated, late-stage biotechnology company developing investigational genetic therapies to address the root causes of complex and rare disorders. Its pipeline uses multiple gene therapy platforms, including programs for rare genetic and cardiovascular diseases such as Danon disease.